OTC:VICP | Cash Flow Statement | Vicapsys Life Sciences, Inc.

Complete source-backed cash-flow history.

Available history
2019-03-31 to 2024-09-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2024-09-30-$235,507.00
2024-06-30-$190,091.00
2024-03-31-$327,072.00-$9,422.00
2023-12-31-$594,803.00-$82,054.00$37,944.00
2023-09-30-$240,340.00
2023-06-30-$135,693.00
2023-03-31-$211,277.00-$9,957.00
2022-12-31-$492,605.00$2,888.00-$15,001.00
2022-09-30-$145,081.00
2022-06-30-$180,056.00
2022-03-31-$167,047.00-$115,976.00
2021-12-31-$103,858.00-$123,254.00$0.00$175,000.00
2021-09-30-$111,181.00
2021-06-30-$72,062.00
2021-03-31$50,230.00-$70,806.00$100,000.00
2020-12-31-$80,549.00-$385.00
2020-09-30-$89,221.00
2020-06-30-$231,615.00
2020-03-31-$364,459.00-$233,218.00
2019-12-31-$249,632.00-$246,480.00$0.00
2019-09-30-$469,340.00
2019-06-30-$248,067.00
2019-03-31-$442,657.00-$187,738.00$104,500.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2023-12-31-$1.18M-$417,524.00$412,849.00
2022-12-31-$984,790.00-$238,197.00$34,999.00
2021-12-31-$236,871.00-$443,974.00$100,000.00$560,000.00
2020-12-31-$765,844.00-$262,897.00
2019-12-31-$1.41M-$970,264.00$1.15M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.